Structure

Physi-Chem Properties

Molecular Weight:  534.21
Volume:  507.72
LogP:  2.063
LogD:  1.179
LogS:  -4.032
# Rotatable Bonds:  4
TPSA:  165.26
# H-Bond Aceptor:  11
# H-Bond Donor:  3
# Rings:  6
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.384
Synthetic Accessibility Score:  6.144
Fsp3:  0.741
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.509
MDCK Permeability:  1.131066801463021e-05
Pgp-inhibitor:  0.008
Pgp-substrate:  0.964
Human Intestinal Absorption (HIA):  0.045
20% Bioavailability (F20%):  0.845
30% Bioavailability (F30%):  0.923

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.407
Plasma Protein Binding (PPB):  54.194271087646484%
Volume Distribution (VD):  0.728
Pgp-substrate:  36.26000213623047%

ADMET: Metabolism

CYP1A2-inhibitor:  0.002
CYP1A2-substrate:  0.749
CYP2C19-inhibitor:  0.01
CYP2C19-substrate:  0.372
CYP2C9-inhibitor:  0.021
CYP2C9-substrate:  0.057
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.118
CYP3A4-inhibitor:  0.243
CYP3A4-substrate:  0.218

ADMET: Excretion

Clearance (CL):  10.081
Half-life (T1/2):  0.837

ADMET: Toxicity

hERG Blockers:  0.003
Human Hepatotoxicity (H-HT):  0.158
Drug-inuced Liver Injury (DILI):  0.571
AMES Toxicity:  0.221
Rat Oral Acute Toxicity:  0.855
Maximum Recommended Daily Dose:  0.826
Skin Sensitization:  0.187
Carcinogencity:  0.147
Eye Corrosion:  0.004
Eye Irritation:  0.051
Respiratory Toxicity:  0.883

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC476851

Natural Product ID:  NPC476851
Common Name*:   methyl 2-[(1R,2R,4S,7R,8S,10S,11R,12R,13R,16R)-10-hydroxy-7-(2-hydroxy-5-oxo-2H-furan-3-yl)-1,8,12,15,15-pentamethyl-5,18-dioxo-3,6,14-trioxapentacyclo[9.7.0.02,4.02,8.012,16]octadecan-13-yl]acetate
IUPAC Name:   methyl 2-[(1R,2R,4S,7R,8S,10S,11R,12R,13R,16R)-10-hydroxy-7-(2-hydroxy-5-oxo-2H-furan-3-yl)-1,8,12,15,15-pentamethyl-5,18-dioxo-3,6,14-trioxapentacyclo[9.7.0.02,4.02,8.012,16]octadecan-13-yl]acetate
Synonyms:  
Standard InCHIKey:  XVYDOXSQOXSOED-PDJNUNDDSA-N
Standard InCHI:  InChI=1S/C27H34O11/c1-23(2)13-8-14(29)26(5)18(25(13,4)15(37-23)9-16(30)34-6)12(28)10-24(3)19(11-7-17(31)35-21(11)32)36-22(33)20-27(24,26)38-20/h7,12-13,15,18-21,28,32H,8-10H2,1-6H3/t12-,13-,15+,18+,19-,20+,21?,24-,25+,26+,27+/m0/s1
SMILES:  C[C@@]12C[C@@H]([C@@H]3[C@@]4([C@@H](CC(=O)[C@]3([C@@]15[C@H](O5)C(=O)O[C@H]2C6=CC(=O)OC6O)C)C(O[C@@H]4CC(=O)OC)(C)C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   90670768
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001125] Steroid lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33678 Clausena emarginata Species Rutaceae Eukaryota stems Xishuangbanna, Yunnan Province, China 2010-AUG PMID[24593150]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT393 Cell Line HCT-116 Homo sapiens IC50 > 10000 nM PMID[24593150]
NPT65 Cell Line HepG2 Homo sapiens IC50 > 10000 nM PMID[24593150]
NPT1820 Cell Line NCI-H1650 Homo sapiens IC50 > 10000 nM PMID[24593150]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 > 10000 nM PMID[24593150]
NPT2 Others Unspecified IC50 > 10000 nM PMID[24593150]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC476851 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9916 High Similarity NPC476852
0.9748 High Similarity NPC476859
0.9667 High Similarity NPC476854
0.9587 High Similarity NPC476855
0.9426 High Similarity NPC476863
0.9426 High Similarity NPC476862
0.871 High Similarity NPC470922
0.871 High Similarity NPC476729
0.8651 High Similarity NPC473620
0.8629 High Similarity NPC67251
0.8629 High Similarity NPC265557
0.8629 High Similarity NPC18945
0.8629 High Similarity NPC105926
0.8629 High Similarity NPC91693
0.8618 High Similarity NPC470779
0.8615 High Similarity NPC251998
0.8605 High Similarity NPC471234
0.8571 High Similarity NPC42399
0.8571 High Similarity NPC298841
0.855 High Similarity NPC295885
0.855 High Similarity NPC140045
0.8548 High Similarity NPC312833
0.8538 High Similarity NPC262813
0.8527 High Similarity NPC168879
0.8512 High Similarity NPC213084
0.8512 High Similarity NPC190185
0.8473 Intermediate Similarity NPC190065
0.8473 Intermediate Similarity NPC471089
0.8473 Intermediate Similarity NPC141215
0.8468 Intermediate Similarity NPC102822
0.8468 Intermediate Similarity NPC477046
0.8455 Intermediate Similarity NPC268958
0.845 Intermediate Similarity NPC102316
0.843 Intermediate Similarity NPC299849
0.8425 Intermediate Similarity NPC476008
0.8425 Intermediate Similarity NPC470780
0.8413 Intermediate Similarity NPC24651
0.8409 Intermediate Similarity NPC596
0.8387 Intermediate Similarity NPC112038
0.8387 Intermediate Similarity NPC107338
0.8387 Intermediate Similarity NPC109607
0.8385 Intermediate Similarity NPC88668
0.8374 Intermediate Similarity NPC297179
0.8374 Intermediate Similarity NPC240509
0.8359 Intermediate Similarity NPC311534
0.8347 Intermediate Similarity NPC94509
0.8346 Intermediate Similarity NPC477745
0.8346 Intermediate Similarity NPC225049
0.8308 Intermediate Similarity NPC478154
0.8306 Intermediate Similarity NPC476529
0.8306 Intermediate Similarity NPC475775
0.8295 Intermediate Similarity NPC175186
0.8295 Intermediate Similarity NPC473593
0.8295 Intermediate Similarity NPC104382
0.8295 Intermediate Similarity NPC472770
0.8293 Intermediate Similarity NPC474483
0.8293 Intermediate Similarity NPC13713
0.8293 Intermediate Similarity NPC146432
0.8293 Intermediate Similarity NPC470778
0.8281 Intermediate Similarity NPC117702
0.8281 Intermediate Similarity NPC287423
0.8281 Intermediate Similarity NPC469757
0.8281 Intermediate Similarity NPC471357
0.8281 Intermediate Similarity NPC146456
0.8264 Intermediate Similarity NPC317687
0.8258 Intermediate Similarity NPC171619
0.825 Intermediate Similarity NPC472666
0.8244 Intermediate Similarity NPC478151
0.824 Intermediate Similarity NPC48692
0.8231 Intermediate Similarity NPC471170
0.8231 Intermediate Similarity NPC478155
0.8231 Intermediate Similarity NPC476074
0.8231 Intermediate Similarity NPC329993
0.8231 Intermediate Similarity NPC475377
0.8231 Intermediate Similarity NPC134914
0.8231 Intermediate Similarity NPC478065
0.8231 Intermediate Similarity NPC301639
0.8231 Intermediate Similarity NPC475167
0.8231 Intermediate Similarity NPC264566
0.8231 Intermediate Similarity NPC173435
0.8231 Intermediate Similarity NPC262796
0.8231 Intermediate Similarity NPC172374
0.8231 Intermediate Similarity NPC45346
0.8231 Intermediate Similarity NPC478064
0.8231 Intermediate Similarity NPC25998
0.8226 Intermediate Similarity NPC17772
0.8226 Intermediate Similarity NPC251310
0.8226 Intermediate Similarity NPC188667
0.8226 Intermediate Similarity NPC470776
0.8226 Intermediate Similarity NPC204552
0.8211 Intermediate Similarity NPC270478
0.8211 Intermediate Similarity NPC235539
0.8211 Intermediate Similarity NPC474046
0.8211 Intermediate Similarity NPC471816
0.8211 Intermediate Similarity NPC134869
0.8211 Intermediate Similarity NPC89929
0.8211 Intermediate Similarity NPC470628
0.8211 Intermediate Similarity NPC152199
0.8211 Intermediate Similarity NPC259306
0.8209 Intermediate Similarity NPC477233
0.8209 Intermediate Similarity NPC477232
0.8203 Intermediate Similarity NPC285091
0.8203 Intermediate Similarity NPC222307
0.8197 Intermediate Similarity NPC159333
0.8197 Intermediate Similarity NPC264153
0.8195 Intermediate Similarity NPC243014
0.8189 Intermediate Similarity NPC27363
0.8189 Intermediate Similarity NPC120724
0.8189 Intermediate Similarity NPC472768
0.8182 Intermediate Similarity NPC317107
0.8175 Intermediate Similarity NPC471999
0.8175 Intermediate Similarity NPC472000
0.8168 Intermediate Similarity NPC180902
0.8168 Intermediate Similarity NPC472769
0.8168 Intermediate Similarity NPC478152
0.8168 Intermediate Similarity NPC478150
0.8168 Intermediate Similarity NPC478153
0.8168 Intermediate Similarity NPC231240
0.8168 Intermediate Similarity NPC475139
0.8154 Intermediate Similarity NPC10823
0.8154 Intermediate Similarity NPC6108
0.8154 Intermediate Similarity NPC251866
0.8154 Intermediate Similarity NPC471352
0.8154 Intermediate Similarity NPC219085
0.8154 Intermediate Similarity NPC471359
0.8154 Intermediate Similarity NPC17896
0.8154 Intermediate Similarity NPC469751
0.8154 Intermediate Similarity NPC471358
0.8154 Intermediate Similarity NPC284406
0.8154 Intermediate Similarity NPC469754
0.8154 Intermediate Similarity NPC471361
0.8154 Intermediate Similarity NPC197707
0.8154 Intermediate Similarity NPC477196
0.8154 Intermediate Similarity NPC469753
0.8154 Intermediate Similarity NPC180079
0.8154 Intermediate Similarity NPC86159
0.8154 Intermediate Similarity NPC70542
0.8154 Intermediate Similarity NPC89514
0.8154 Intermediate Similarity NPC9499
0.8154 Intermediate Similarity NPC471360
0.8154 Intermediate Similarity NPC469752
0.8154 Intermediate Similarity NPC469755
0.8145 Intermediate Similarity NPC473968
0.8145 Intermediate Similarity NPC470854
0.8145 Intermediate Similarity NPC469684
0.8145 Intermediate Similarity NPC470775
0.8145 Intermediate Similarity NPC97908
0.8145 Intermediate Similarity NPC176513
0.8145 Intermediate Similarity NPC473590
0.8145 Intermediate Similarity NPC287343
0.8145 Intermediate Similarity NPC122033
0.8145 Intermediate Similarity NPC474654
0.813 Intermediate Similarity NPC181145
0.813 Intermediate Similarity NPC474906
0.813 Intermediate Similarity NPC18547
0.813 Intermediate Similarity NPC473798
0.813 Intermediate Similarity NPC469877
0.813 Intermediate Similarity NPC470919
0.8125 Intermediate Similarity NPC8369
0.8116 Intermediate Similarity NPC48813
0.8116 Intermediate Similarity NPC194854
0.8115 Intermediate Similarity NPC269530
0.811 Intermediate Similarity NPC473231
0.811 Intermediate Similarity NPC471965
0.8106 Intermediate Similarity NPC316915
0.8099 Intermediate Similarity NPC476766
0.8095 Intermediate Similarity NPC476150
0.8095 Intermediate Similarity NPC109973
0.8095 Intermediate Similarity NPC476127
0.8095 Intermediate Similarity NPC472004
0.8092 Intermediate Similarity NPC477197
0.8083 Intermediate Similarity NPC476765
0.8083 Intermediate Similarity NPC322903
0.808 Intermediate Similarity NPC234522
0.8077 Intermediate Similarity NPC477078
0.8077 Intermediate Similarity NPC475636
0.8077 Intermediate Similarity NPC477191
0.8077 Intermediate Similarity NPC329923
0.8077 Intermediate Similarity NPC470475
0.8077 Intermediate Similarity NPC477194
0.8077 Intermediate Similarity NPC477192
0.8077 Intermediate Similarity NPC295220
0.8077 Intermediate Similarity NPC477075
0.8077 Intermediate Similarity NPC475281
0.8077 Intermediate Similarity NPC470476
0.8077 Intermediate Similarity NPC477193
0.8077 Intermediate Similarity NPC188291
0.8077 Intermediate Similarity NPC270109
0.8065 Intermediate Similarity NPC96312
0.8065 Intermediate Similarity NPC476710
0.8065 Intermediate Similarity NPC474734
0.8065 Intermediate Similarity NPC476711
0.8065 Intermediate Similarity NPC40632
0.8065 Intermediate Similarity NPC328374
0.8065 Intermediate Similarity NPC173686
0.8065 Intermediate Similarity NPC16081
0.8065 Intermediate Similarity NPC251236
0.8062 Intermediate Similarity NPC217901
0.8062 Intermediate Similarity NPC250556
0.8062 Intermediate Similarity NPC87662

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476851 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8154 Intermediate Similarity NPD7319 Approved
0.8062 Intermediate Similarity NPD7507 Approved
0.8047 Intermediate Similarity NPD8328 Phase 3
0.8 Intermediate Similarity NPD8293 Discontinued
0.7969 Intermediate Similarity NPD6370 Approved
0.7939 Intermediate Similarity NPD7736 Approved
0.7934 Intermediate Similarity NPD6686 Approved
0.7846 Intermediate Similarity NPD7492 Approved
0.7812 Intermediate Similarity NPD6054 Approved
0.7812 Intermediate Similarity NPD6059 Approved
0.7787 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7786 Intermediate Similarity NPD6616 Approved
0.7727 Intermediate Similarity NPD7078 Approved
0.7661 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7656 Intermediate Similarity NPD7327 Approved
0.7656 Intermediate Similarity NPD7328 Approved
0.7615 Intermediate Similarity NPD6015 Approved
0.7615 Intermediate Similarity NPD6016 Approved
0.7597 Intermediate Similarity NPD7516 Approved
0.7581 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD7115 Discovery
0.7557 Intermediate Similarity NPD5988 Approved
0.7538 Intermediate Similarity NPD6319 Approved
0.7481 Intermediate Similarity NPD8517 Approved
0.7481 Intermediate Similarity NPD8515 Approved
0.7481 Intermediate Similarity NPD8513 Phase 3
0.7481 Intermediate Similarity NPD8516 Approved
0.744 Intermediate Similarity NPD6372 Approved
0.744 Intermediate Similarity NPD6373 Approved
0.7419 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD8377 Approved
0.7405 Intermediate Similarity NPD8294 Approved
0.7402 Intermediate Similarity NPD8297 Approved
0.7402 Intermediate Similarity NPD6882 Approved
0.736 Intermediate Similarity NPD7320 Approved
0.7348 Intermediate Similarity NPD8378 Approved
0.7348 Intermediate Similarity NPD8033 Approved
0.7348 Intermediate Similarity NPD8380 Approved
0.7348 Intermediate Similarity NPD8335 Approved
0.7348 Intermediate Similarity NPD8379 Approved
0.7348 Intermediate Similarity NPD8296 Approved
0.7339 Intermediate Similarity NPD6402 Approved
0.7339 Intermediate Similarity NPD5739 Approved
0.7339 Intermediate Similarity NPD6675 Approved
0.7339 Intermediate Similarity NPD7128 Approved
0.7323 Intermediate Similarity NPD6650 Approved
0.7323 Intermediate Similarity NPD6649 Approved
0.7308 Intermediate Similarity NPD6009 Approved
0.7279 Intermediate Similarity NPD6033 Approved
0.7273 Intermediate Similarity NPD4225 Approved
0.7222 Intermediate Similarity NPD6881 Approved
0.7222 Intermediate Similarity NPD6899 Approved
0.7218 Intermediate Similarity NPD6921 Approved
0.7213 Intermediate Similarity NPD7639 Approved
0.7213 Intermediate Similarity NPD7640 Approved
0.72 Intermediate Similarity NPD6008 Approved
0.7165 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5701 Approved
0.7143 Intermediate Similarity NPD5697 Approved
0.7143 Intermediate Similarity NPD6412 Phase 2
0.7131 Intermediate Similarity NPD7638 Approved
0.7111 Intermediate Similarity NPD7604 Phase 2
0.7109 Intermediate Similarity NPD7290 Approved
0.7109 Intermediate Similarity NPD6883 Approved
0.7109 Intermediate Similarity NPD7102 Approved
0.7077 Intermediate Similarity NPD8133 Approved
0.7077 Intermediate Similarity NPD4632 Approved
0.7054 Intermediate Similarity NPD6847 Approved
0.7054 Intermediate Similarity NPD6869 Approved
0.7054 Intermediate Similarity NPD6617 Approved
0.7054 Intermediate Similarity NPD8130 Phase 1
0.7031 Intermediate Similarity NPD6014 Approved
0.7031 Intermediate Similarity NPD6013 Approved
0.7031 Intermediate Similarity NPD6012 Approved
0.6963 Remote Similarity NPD7503 Approved
0.6963 Remote Similarity NPD5983 Phase 2
0.6957 Remote Similarity NPD8074 Phase 3
0.6953 Remote Similarity NPD6011 Approved
0.6923 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6884 Remote Similarity NPD6336 Discontinued
0.6879 Remote Similarity NPD7260 Phase 2
0.6875 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6855 Remote Similarity NPD5696 Approved
0.6846 Remote Similarity NPD4634 Approved
0.6846 Remote Similarity NPD6371 Approved
0.6833 Remote Similarity NPD46 Approved
0.6833 Remote Similarity NPD6698 Approved
0.6831 Remote Similarity NPD6845 Suspended
0.6825 Remote Similarity NPD5211 Phase 2
0.6774 Remote Similarity NPD4755 Approved
0.6774 Remote Similarity NPD6084 Phase 2
0.6774 Remote Similarity NPD6083 Phase 2
0.6759 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6746 Remote Similarity NPD5344 Discontinued
0.6739 Remote Similarity NPD6067 Discontinued
0.6719 Remote Similarity NPD5141 Approved
0.6716 Remote Similarity NPD6274 Approved
0.6693 Remote Similarity NPD7632 Discontinued
0.6691 Remote Similarity NPD7100 Approved
0.6691 Remote Similarity NPD7101 Approved
0.6667 Remote Similarity NPD4696 Approved
0.6667 Remote Similarity NPD5285 Approved
0.6667 Remote Similarity NPD5282 Discontinued
0.6667 Remote Similarity NPD4700 Approved
0.6667 Remote Similarity NPD5286 Approved
0.664 Remote Similarity NPD7902 Approved
0.6618 Remote Similarity NPD6335 Approved
0.6617 Remote Similarity NPD6053 Discontinued
0.6613 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6594 Remote Similarity NPD6909 Approved
0.6594 Remote Similarity NPD6908 Approved
0.6594 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6573 Remote Similarity NPD5956 Approved
0.6566 Remote Similarity NPD7799 Discontinued
0.6562 Remote Similarity NPD5224 Approved
0.6562 Remote Similarity NPD4633 Approved
0.6562 Remote Similarity NPD5225 Approved
0.6562 Remote Similarity NPD5226 Approved
0.656 Remote Similarity NPD4697 Phase 3
0.6544 Remote Similarity NPD6317 Approved
0.6538 Remote Similarity NPD4768 Approved
0.6538 Remote Similarity NPD4767 Approved
0.6535 Remote Similarity NPD6648 Approved
0.6532 Remote Similarity NPD7748 Approved
0.6512 Remote Similarity NPD5174 Approved
0.6512 Remote Similarity NPD5175 Approved
0.6504 Remote Similarity NPD7515 Phase 2
0.65 Remote Similarity NPD7642 Approved
0.6496 Remote Similarity NPD6314 Approved
0.6496 Remote Similarity NPD6313 Approved
0.6484 Remote Similarity NPD5223 Approved
0.6484 Remote Similarity NPD1700 Approved
0.648 Remote Similarity NPD5695 Phase 3
0.648 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6475 Remote Similarity NPD5328 Approved
0.6471 Remote Similarity NPD6868 Approved
0.6463 Remote Similarity NPD8387 Clinical (unspecified phase)
0.6457 Remote Similarity NPD8029 Clinical (unspecified phase)
0.6452 Remote Similarity NPD5778 Approved
0.6452 Remote Similarity NPD5779 Approved
0.6452 Remote Similarity NPD6399 Phase 3
0.6439 Remote Similarity NPD4729 Approved
0.6439 Remote Similarity NPD4730 Approved
0.6429 Remote Similarity NPD5222 Approved
0.6429 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6429 Remote Similarity NPD5221 Approved
0.6429 Remote Similarity NPD8080 Discontinued
0.64 Remote Similarity NPD7900 Approved
0.64 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6393 Remote Similarity NPD5737 Approved
0.6393 Remote Similarity NPD6672 Approved
0.6385 Remote Similarity NPD4754 Approved
0.6383 Remote Similarity NPD7829 Approved
0.6383 Remote Similarity NPD7830 Approved
0.6378 Remote Similarity NPD5173 Approved
0.6376 Remote Similarity NPD6334 Approved
0.6376 Remote Similarity NPD6333 Approved
0.6371 Remote Similarity NPD6411 Approved
0.6371 Remote Similarity NPD7983 Approved
0.6371 Remote Similarity NPD5693 Phase 1
0.6371 Remote Similarity NPD6079 Approved
0.637 Remote Similarity NPD8338 Approved
0.6364 Remote Similarity NPD3618 Phase 1
0.6349 Remote Similarity NPD4629 Approved
0.6349 Remote Similarity NPD5210 Approved
0.6345 Remote Similarity NPD6914 Discontinued
0.6343 Remote Similarity NPD5249 Phase 3
0.6343 Remote Similarity NPD5248 Approved
0.6343 Remote Similarity NPD5247 Approved
0.6343 Remote Similarity NPD5251 Approved
0.6343 Remote Similarity NPD5250 Approved
0.6336 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6319 Remote Similarity NPD8337 Approved
0.6319 Remote Similarity NPD8336 Approved
0.6316 Remote Similarity NPD5128 Approved
0.6311 Remote Similarity NPD3573 Approved
0.6303 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6284 Remote Similarity NPD8415 Approved
0.6281 Remote Similarity NPD1694 Approved
0.6241 Remote Similarity NPD8274 Clinical (unspecified phase)
0.6241 Remote Similarity NPD8444 Approved
0.621 Remote Similarity NPD6904 Approved
0.621 Remote Similarity NPD6673 Approved
0.621 Remote Similarity NPD6080 Approved
0.621 Remote Similarity NPD6101 Approved
0.621 Remote Similarity NPD5764 Clinical (unspecified phase)
0.621 Remote Similarity NPD4753 Phase 2
0.6207 Remote Similarity NPD8407 Phase 2
0.6198 Remote Similarity NPD6400 Clinical (unspecified phase)
0.619 Remote Similarity NPD4202 Approved
0.6181 Remote Similarity NPD8451 Approved
0.6176 Remote Similarity NPD5217 Approved
0.6176 Remote Similarity NPD5215 Approved
0.6176 Remote Similarity NPD5216 Approved
0.6172 Remote Similarity NPD7839 Suspended
0.616 Remote Similarity NPD5785 Approved
0.616 Remote Similarity NPD7838 Discovery
0.6154 Remote Similarity NPD7625 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data